CRYOPORT, INC. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
CRYOPORT, INC. (CYRX) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-10.
Discontinued › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2020-03-10
- CRYOPORT, INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2019-12-31 was $0.00.
- CRYOPORT, INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2019-09-30 was $0.00.
- CRYOPORT, INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2018-12-31 was $0.00.
- CRYOPORT, INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2018-09-30 was $0.00.
- CRYOPORT, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2019 was $0.00.
- CRYOPORT, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2018 was $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 3 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 6 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 9 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $0.00 derived: sum of 2 quarters · filed 2020-03-10 | $0.00 10-K · filed 2020-03-10 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $0.00 derived: sum of 2 quarters · filed 2020-03-10 | $0.00 10-K · filed 2020-03-10 | |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |